News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Neurotech Market Summary: Targacept, Inc. And Northstar Neuroscience, Inc. Added To Neurotech Index



7/5/2006 7:01:24 PM

Amarin (AMRN) was the top gainer in June after recovering from profit taking in May. The company has shown continued progress in their pipeline, including completion of enrollment in the Phase III trial of Miraxion for Huntington’s disease. Endo Pharmaceuticals (ENDP) saw gains after announcing the launch of Synera anesthetic patch and approval of Opana (see page 4 & 5). Medivation (MDV), a company developing the neuroprotectant Dimebon for Alzheimer’s disease, gained ground after investors took speculative note of upcoming Phase II trial announcements…

Read at Neuroinsights


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES